| Title | Update: Methicillin-resistant Staphylococcus aureus screening and decolonization in cardiac surgery. | | Author(s) | Tom TS, Kruse MW, Reichman RT | | Institution | Department of Pharmacy, Deaconess Medical Center, Washington State University, Spokane, Washington, USA. | | Source | Ann Thorac Surg 2009 Aug; 88(2):695-702. | | MeSH | Anti-Bacterial Agents
Antibiotic Prophylaxis
Cardiac Surgical Procedures
Cefazolin
Cost-Benefit Analysis
Humans
Mediastinitis
Methicillin-Resistant Staphylococcus aureus
Population Surveillance
Practice Guidelines as Topic
Staphylococcal Infections
Surgical Wound Infection
United States
| | Abstract | Methicillin-resistant Staphylococcus aureus (MRSA) has become a concerning multidrug-resistant organism, expanding further outside the hospital setting. Cardiothoracic surgery patients are at an increased risk for mediastinitis and other surgical site infections, which may be further complicated by MRSA. To reduce MRSA surgical site infections, multidisciplinary active surveillance should be implemented in at least high-risk patients, incorporating basic infection control practices, appropriate antibiotic prophylaxis, and decolonization. This article will review the various guidelines, addressing the role of MRSA active surveillance in cardiothoracic surgery, and provide guidance for cardiothoracic surgeons. | | Language | eng | | Pub Type(s) | Journal Article
Review
| | PubMed ID | 19632455 |
|
